Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (“Rakovina”), a biopharmaceutical company advancing innovative cancer therapies through AI-powered drug discovery and Variational AI, a leader in ...

Variational AI, a Vancouver-based Healthcare Tech Company, advances Generative AI Drug Discovery by designing novel small ...

Researchers have proposed a unifying mathematical framework that helps explain why many successful multimodal AI systems work ...

Variational Autoencoders (VAEs) are an artificial neural network architecture to generate new data. They are similar to regular autoencoders, which consist of an encoder and decoder. The encoder takes ...

Merck & Co. has doubled down on its partnership with Variational AI, striking a deal worth up to $349 million to collaborate on small molecule candidates against two targets. Variational disclosed a ...